아시아 태평양 혈관성형술 풍선 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 통찰력 아시아 태평양 혈관성형술 풍선 시장 혈관성형술 풍선

혈관성형술 풍선 시장은 2022년부터 2029년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에 언급된 예측 기간 동안 시장이 1.4%의 CAGR로 성장할 것으로 분석합니다.

혈관성형술 풍선(경피적 관상동맥 혈관성형술이라고도 함)은 기본적으로 동맥 죽상경화증을 치료하기 위해 좁아지거나 막힌 동맥이나 정맥을 여는 데 사용되는 최소 침습적 혈관 내 시술입니다. 동맥에 삽입된 카테터에 부착된 풍선을 사용한 다음, 플라그 침전물이 좁아지거나 혈류 통로를 막은 동일한 위치에서 풍선을 부풀립니다. 혈관성형술 풍선에는 일반 풍선 혈관성형술, 약물 코팅 풍선(DCB) 혈관성형술, 절단 풍선, 스코어링 풍선, 스텐트 그래프트 풍선 카테터 등 다양한 유형이 있으며, 카테터실, 병원, 전문 진료소, 외래 수술 센터 및 진단 센터와 같은 다양한 최종 용도에서 널리 사용됩니다.

The growing number of increase in the incidence of cardiovascular diseases with heart diseases becoming a major cause of fatalities along with increase in the geriatric population in both developed and developing countries and are the significant factors responsible for driving the growth of the angioplasty balloons market in the above-mentioned forecast period. Moreover, the factors such as various technological advancements, increasing healthcare expenditure and increasing preference for minimally invasive procedures as compared to conventional surgeries, the various benefits of minimally invasive surgeries such as reduced surgical pain, injury, scarring, hospital stay, higher accuracy, and speedy recovery time are encouraging more patients to opt for minimally invasive balloon angioplasty surgeries are estimated to boost the market’s growth. Additionally, the growing incidence of target disease and the favorable government policies and increasing coronary and peripheral interventions also heighten the overall growth of the market. On the other hand, the factors such as high costs associated with the procedure coupled with stiffness of the device are estimated to obstruct the market’s growth in the forecast period of 2022 to 2029. The high investment in research and development is also one of the restraint that hampers the overall growth of the market.

Furthermore, the growing awareness created by medical professionals and key players about the benefits of angioplasty balloons and increasing technological advancements and incorporation of innovation in the industry are expected to generate profitable opportunities for the market. On the flip side, the complications associated with angioplasty procedures obstruct the market’s growth and have the potential to challenge for the market’s growth.

This angioplasty balloons market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research angioplasty balloons market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Asia-Pacifica Angioplasty Balloons Market Scope and Market Size

Angioplasty balloons market is segmented on the basis of type, material, balloon type, disease indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the angioplasty balloons market is segmented into plain old balloon angioplasty, drug-coated balloon (DCB) angioplasty, cutting balloons, scoring balloons, and stent graft balloon catheter.
• On the basis of material, the angioplasty balloons market is segmented into nylon, polyurethane, silicone urethane co-polymers and other.
• On the basis of balloon type, the angioplasty balloons market is segmented into semi-compliant and non-compliant.
• On the basis of disease indication, the angioplasty balloons market is segmented into coronary angioplasty, venous angioplasty, carotid angioplasty, renal artery angioplasty and peripheral angioplasty.
• On the basis of end user, the angioplasty balloons market is segmented into cath labs, hospitals, specialty clinics, ambulatory surgery centers and diagnostic centers.

Asia-Pacific Angioplasty Balloons Market Country Level Analysis

Angioplasty balloons market is segmented on the basis of type, material, balloon type, disease indication and end user.

The countries covered in the Asia-Pacific angioplasty balloons market report are Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific

The country section of the angioplasty balloons market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacifica brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

혈관성형술 풍선 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 혈관성형술 풍선 시장을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용하는 기술의 영향, 의료 규제 시나리오의 변화 및 혈관성형술 풍선 시장에 미치는 영향. 이 데이터는 2010년부터 2020년까지의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 혈관성형술 풍선 시장 점유율 분석

혈관성형술 풍선 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 아시아 태평양 지역 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 혈관성형술 풍선 시장과 관련된 회사의 초점에만 관련이 있습니다.

혈관성형술 풍선 시장 보고서에서 활동하는 주요 기업으로는 Medtronic, BD, Boston Scientific Corporation, Abbott, AngioDynamics, B. Braun Melsungen AG., Biomerics, BIOTRONIK, Cook, Cardinal Health, Hexacath, JOTEC GmbH, CTK biotech, Inc, Koninklijke Philips NV., MicroPort Scientific Corporation, Panmed Health-care, Nipro Medical Corporation, Palex Medical, Stryker, Teleflex Incororated, Terumo Corporation 등이 있습니다.

SKU-24539